February 1, 2008 - Volume 47 - Issue 2 - Contributor Index

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 47(2):212-220, February 1, 2008.

Changes in Outcome of Persons Initiating Highly Active Antiretroviral Therapy at a CD4 Count Less Than 50 Cells/mm3

Porter, Kholoud; Walker, Sarah; Hill, Teresa; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 47(2):202-205, February 1, 2008.

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive Patients

(Niel) Malan, D. R; Krantz, Edrich; David, Neal; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 47(2):161-167, February 1, 2008.

Dual Nucleoside Reverse Transcriptase Inhibitor Therapy in the Combination Antiretroviral Therapy Era and Predictors of Discontinuation or Switch to Combination Antiretroviral...

Selinger-Leneman, Hana; Matheron, Sophie; Mahamat, Aba; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 47(2):206-211, February 1, 2008.

Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy: PISCIS Cohort (Spain)

Jaén, Ángeles; Esteve, Anna; Miró, Josep M; More

JAIDS Journal of Acquired Immune Deficiency Syndromes . 47(2):212-220, February 1, 2008.